https://www.selleckchem.com/pr....oducts/ly3295668.htm
Nanosheet-loading therefore provides a promising approach for improving CAR-T cell therapeutic efficacy in solid tumors. Immune-checkpoint inhibition has improved outcomes in metastatic melanoma. However, limited data describes the safety and efficacy of this treatment in the setting of cardiac allograft. Emerging translational and clinical evidence suggests that the majority of the benefit from these therapies is driven by the initial dose(s), and that attenuated dosing schedules may be as effective as continuous treatment. We presen
Like
Comment
Share
